Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)
Antimicrobial Agents and Chemotherapy · 18.04.2023 · 67 (4)
DOI: 10.1128/aac.01193-22 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 18.04.2023. Verfasst von Jaime Altcheh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Parasitología, Hospital de Niños Ricardo Gutiérrez and Instituto Multidisciplinario de Investigacion en Patologias Pediatricas (IMIPP), CONICET-GCBA,…. Hauptthemen laut MEDLINE: Trypanocidal Agents, Chagas Disease, Nitroimidazoles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nifurtimox is recommended for the treatment of Chagas disease; however, long-term follow-up data are scarce. This prolonged follow-up phase of the prospective, historically controlled, CHICO clinical trial evaluated seronegative conversion in pediatric patients aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Parasitología, Hospital de Niños Ricardo Gutiérrez and Instituto Multidisciplinario de Investigacion en Patologias Pediatricas (IMIPP), CONICET-GCBA, Buenos Aires, Argentina.
- Centro de Atención e Investigación Médica S.A., Yopal, Colombia.
- Centro de Enfermedad de Chagas y Patologias Regionales, Santiago del Estero, Argentina.
- Fundación CEADES-Plataforma de Atención Integral a los Pacientes con Enfermedades de Chagas, Cochabamba, Bolivia.
- Bayer AG, Research and Development Pharmaceuticals, Berlin, Germany.
- Bayer US LLC, Whippany, New Jersey, USA.
ORCID-Profile: Jaime Altcheh
Zitieren
APA
Altcheh, J., Sierra, V., Ramirez, T., Pinto Rocha, J. J., Grossmann, U., Huang, E., Moscatelli, G., & Ding, O. (2023). Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE). Antimicrobial Agents and Chemotherapy, 67(4). https://doi.org/10.1128/aac.01193-22
Vancouver
Altcheh J, Sierra V, Ramirez T, Pinto Rocha JJ, Grossmann U, Huang E, et al. Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE). Antimicrobial Agents and Chemotherapy. 2023;67(4). doi:10.1128/aac.01193-22
BibTeX
@article{Altcheh2023,
author = {Altcheh, Jaime and Sierra, Victor and Ramirez, Teresa and Pinto Rocha, Jimy José and Grossmann, Ulrike and Huang, Erya and Moscatelli, Guillermo and Ding, Olivia},
title = {Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {4},
doi = {10.1128/aac.01193-22}
}
EUVIMED